New rapid TB test could predict treatment success in kenya
NCT ID NCT07157904
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This study will test a new rapid test called PATHFAST TB LAM to see if it can help monitor treatment for tuberculosis (TB). Researchers will follow 300 adults in Nairobi, Kenya, during their 6-month TB treatment, collecting sputum and urine samples at regular visits. The goal is to see if changes in a TB bacterial substance called LAM can predict whether treatment is working or if a patient is at risk of a poor outcome. If successful, this test could provide a faster, simpler way to monitor TB treatment in resource-limited settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mbagathi County Referral Hospital
Nairobi, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rhodes Chest Clinic
Nairobi, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.